Daclizumab
Daclizumab (Zenapax) is a humanized monoclonal antibody that specifically inhibits the alpha subunit of IL-2R-HA. Daclizumab (Zenapax) can inhibit the binding of IL-2 and IL-2R-HA through specific binding to CD25. Daclizumab (Zenapax) studies multiple sclerosis.
Product Specifications
CAS Number
152923-56-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6520507 1.0 µg DNA
Ndufa1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details 
JOT-EK0232FI 96 wells
Fish Fibroblast Growth Factor 23,FGF23 ELISA KIT
Sign In for Pricing
View Details